Xtant Medical Holdings (XTNT) Pre-Announces Record Q3 Revenues of $23-$23.3M

October 11, 2016 7:33 AM EDT
Get Alerts XTNT Hot Sheet
Price: $0.51 +4.08%

Today's EPS Names:
VRNT, OLLI, HRB, More
Trade XTNT Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Xtant Medical Holdings, Inc. (NYSE: XTNT) pre-announced that its record Third Quarter 2016 revenue is expected to be in the range of $23.0 million to $23.3 million, a 10.0%-11.5% increase compared to pro forma third quarter of 2015 revenue and a 7.2%-8.6% sequential increase compared to the second quarter of 2016.

($000's)Q3 2016Q2 2016 Q3 2015*
Low High Actual ResultsPro Forma Results
Revenue $23,000 $23,300 $21,462 $20,902*
Q-QGrowth 7.2% 8.6%
Y-YGrowth 10.0% 11.5%

*Pro Forma Results

*Use of Pro Forma Financial Information

On July 31, 2015, Bacterin International Holdings, Inc. acquired all of the issued and outstanding stock of X-Spine Systems, Inc. and the combined company was renamed Xtant Medical Holdings, Inc. Except for the financial results for the three months ended June 30, 2016, the results presented are on a pro forma basis as if the two companies were combined for the periods shown. Certain pro forma adjustments have been made to reflect the impact of the purchase transaction, primarily consisting of amortization of intangible assets with determinable lives and interest expense on long-term debt. In addition, certain historical expenses, such as warrant expense and interest expense associated with debt that was immediately repaid, were eliminated from these pro forma results. The pro forma information does not necessarily reflect the actual results of operations had the acquisition been consummated at the beginning of the fiscal reporting period indicated nor is it indicative of future operating results. The pro forma information does not include any adjustment for potential revenue enhancements, cost synergies or other operating efficiencies that could result from the acquisition.

Additional information regarding the business combination and its impact on the Company’s financial position will be set forth in the Company’s Form 10-Q for the quarter ended September 30, 2016, which will be filed with the Securities and Exchange Commission November, 2016 and will include the Company’s audited consolidated financial statements as of and for the quarters ended September 30, 2016 and September 30, 2015.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Guidance

Related Entities

Dividend, Earnings, Definitive Agreement

Add Your Comment